Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years

NCT00874549 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Infections
Meningococcal Meningitis

Interventions

BIOLOGICAL: Menomune®: A, C, Y, W-135 Meningococcal Polysaccharide
BIOLOGICAL: Menactra®: Polysaccharide Diphtheria Toxoid Conjugate
BIOLOGICAL: Menactra®: Polysaccharide Diphtheria Toxoid Conjugate
BIOLOGICAL: Menactra®: Polysaccharide Diphtheria Toxoid Conjugate

Sponsor

Sanofi Pasteur, a Sanofi Company